High-dose steroid therapy for CNS inflammatory diseases increases INR in patients taking oral vitamin K antagonist.

Stefano Gelibter, Mario Orrico, Tommaso Croese, Luca Bosco, Vittorio Martinelli, Francesca Sangalli, Massimo Filippi

Journal: Journal of neurology 2020;266(12):3160-3161

PMID: 31435772

Abstract

Address: Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. [email protected].; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. [email protected].; Vita-Salute San Raffaele University, Milan, Italy. [email protected].

DOI: 10.1007/s00415-019-09515-6

Link outs

Free resources

Medical:

https://medlineplus.gov/bloodthinners.html

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/s00415-019-09515-6

MeSH Terms: Aged, Anticoagulants, Demyelinating Autoimmune Diseases, CNS, Female, Glucocorticoids, Humans, International Normalized Ratio, Male, Methylprednisolone, Middle Aged, Vitamin K, Warfarin